| Note |
Because Alzheimer's patients lose more than memory… Exelon provides proven benefits in activies of daily living (ADL). Helps preserve cognitive performance. Offers maximized individual benefits through personalized dosing. Offers an excellent safety profile plus proven tolerability. Exelon addresses 'Function-ability' For Alzheimer's patients a better today… Exelon, the most you can do to help preserve 'Function-ability'. Prescribing information: Presentation: Capsules containing 1.5 mg, 3.0 mg, 4.5 mg or 6.0 mg revastigmine (as hydrogen tartrate). Indication: Mild to moderately sever dementia of the Alzheimer type. Dosage: 1.5 mg. twice daily is the recommended starting dose. If well tolerated, it may be increased after a minimum of 2 weeks of treatment to 3 mg twice daily, subsequently 4.5mg twice daily, up to a maximum of 6 mg twice daily. Adverse effects may respond to omitting one or more doses. If they persist, the daily dose should be reduce to the previous well tolerated dose. Contraindications: Known hypersensitivity to rivastigmine, other carbamate derivatives, or excipients of the capsules. Precautions/Warnings: Sick sinus syndrome, severe cardiac arrhythmias, gastroduodenal ulcerative conditions in predisposed patients, respiratory disease, urinary obstruction, seizure, pregnancy and lactation. Interactions: Cholinomimetic drugs, anticholinergic medications. Adverse reactions: Nausea, vomiting, diarrhea, abdominal paint, loss of appetite, dyspepsia, dizziness, headache. Packs: Bottle of 60 capsules of 1.5 mg, 3.0 mg, 4.5 mg or 6.0 mg. Note: before prescribing please read full product information. |
